OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
IDR-targeting compounds suppress HPV genome replication via disruption of phospho-BRD4 association with DNA damage response factors
Shwu‐Yuan Wu, Hsien‐Tsung Lai, N. Sanjib Banerjee, et al.
Molecular Cell (2023) Vol. 84, Iss. 2, pp. 202-220.e15
Closed Access | Times Cited: 9
Shwu‐Yuan Wu, Hsien‐Tsung Lai, N. Sanjib Banerjee, et al.
Molecular Cell (2023) Vol. 84, Iss. 2, pp. 202-220.e15
Closed Access | Times Cited: 9
Showing 9 citing articles:
An updated patent review of BRD4 degraders
Zonghui Ma, Cun Zhang, Andrew A. Bolinger, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 10, pp. 929-951
Closed Access | Times Cited: 6
Zonghui Ma, Cun Zhang, Andrew A. Bolinger, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 10, pp. 929-951
Closed Access | Times Cited: 6
A Minireview on BET Inhibitors: Beyond Bromodomain Targeting
Mikhail Iudin, Yu. M. Khodarovich, Anna M. Varizhuk, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 594-594
Open Access
Mikhail Iudin, Yu. M. Khodarovich, Anna M. Varizhuk, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 594-594
Open Access
Discovery of a brain-permeable bromodomain and extra terminal domain (BET) inhibitor with selectivity for BD1 for the treatment of multiple sclerosis
Xuetao Chen, Tingting Wu, Zhiyan Du, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116080-116080
Closed Access | Times Cited: 7
Xuetao Chen, Tingting Wu, Zhiyan Du, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116080-116080
Closed Access | Times Cited: 7
Targeting bromodomian-containing protein 8 (BRD8): An advanced tool to interrogate BRD8
Tingting Wu, Yali Chen, Qidong You, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116271-116271
Closed Access | Times Cited: 1
Tingting Wu, Yali Chen, Qidong You, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116271-116271
Closed Access | Times Cited: 1
Novel BRD4-p53 Inhibitor SDU-071 Suppresses Proliferation and Migration of MDA-MB-231 Triple-Negative Breast Cancer Cells
Shumei Wang, Kang Lei, Hsien‐Tsung Lai, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 4, pp. 1178-1190
Closed Access | Times Cited: 1
Shumei Wang, Kang Lei, Hsien‐Tsung Lai, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 4, pp. 1178-1190
Closed Access | Times Cited: 1
Control of Inflammatory Response by Tissue Microenvironment
Zhongyang Wu, Scott D. Pope, Nasiha S. Ahmed, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Zhongyang Wu, Scott D. Pope, Nasiha S. Ahmed, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
BRD4 as an emerging epigenetic therapeutic target for inflammatory bowel disease
Zonghui Ma, Andrew A. Bolinger, Irina V. Pinchuk, et al.
Advances in pharmacology (2024), pp. 203-236
Closed Access | Times Cited: 1
Zonghui Ma, Andrew A. Bolinger, Irina V. Pinchuk, et al.
Advances in pharmacology (2024), pp. 203-236
Closed Access | Times Cited: 1
Bromodomain containing 4 inhibition combats gastric precancerous lesions via modulating macrophage polarization
Lei Zhu, Qingxin Cai, Gang Li, et al.
Tissue and Cell (2024) Vol. 91, pp. 102580-102580
Closed Access
Lei Zhu, Qingxin Cai, Gang Li, et al.
Tissue and Cell (2024) Vol. 91, pp. 102580-102580
Closed Access
BRD4 Degradation Enhanced Glioma Sensitivity to Temozolomide by Regulating Notch1 via Glu‐Modified GSH‐Responsive Nanoparticles
Linbin Yi, Zhenyu Zhang, Wenjie Zhou, et al.
Advanced Science (2024)
Open Access
Linbin Yi, Zhenyu Zhang, Wenjie Zhou, et al.
Advanced Science (2024)
Open Access
